Efficacy of chronic antidepressant treatments in a new model of extreme anxiety in rats

Depression Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Javelot, Hervé ^a,b,c   Weiner, Luisa ^d   Terramorsi, Roxane ^a   Rougeot, Catherine ^e   Lalonde, Robert ^f   Messaoudi, Michaël ^a  

^a ETAP Applied Ethology   (France)

^b Service G06   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e INSTITUT PASTEUR   (France)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861462370     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2011/531435     Document Type: Article

References (95)

1. Misslin R., The defense system of fear: behavior and neurocircuitry. Neurophysiologie Clinique 2003 33 2 55 66 2-s2.0-0038300732 10.1016/S0987- 7053(03)00009-1 (Pubitemid 36841389)
2. Blanchard D. C., Griebel G., Blanchard R. J., Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews 2001 25 3 205 218 2-s2.0-0034989828 10.1016/S0149-7634(01) 00009-4 (Pubitemid 32506874)
3. Blanchard D. C., Griebel G., Blanchard R. J., The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. European Journal of Pharmacology 2003 463 1-3 97 116 2-s2.0-0037470186 10.1016/S0014-2999(03)01276-7 (Pubitemid 36205074)
4. Pobbe R. L., Zangrossi H., Blanchard D. C., Blanchard R. J., Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. European Neuropsychopharmacology 2010 21 4 306 315 2-s2.0-77952735345 10.1016/j.euroneuro.2010.05.004
5. Blanchard R. J., Blanchard D. C., Passive and active reactions to fear-eliciting stimuli. Journal of Comparative and Physiological Psychology 1969 68 1 129 135 2-s2.0-0014515102 10.1037/h0027676
6. Blanchard R. J., Blanchard D. C., Takahashi T., Kelley M. J., Attack and defensive behaviour in the albino rat. Animal Behaviour 1977 25 3 622 634 2-s2.0-0017691947 (Pubitemid 8192177)
7. Fanselow M. S., Neural organization of the defensive behavior system responsible for fear. Psychonomic Bulletin & Review 1994 1 429 438
8. Blanchard R. J., Flannelly K. J., Blanchard D. C., Defensive behavior of laboratory and wild Rattus norvegicus. Journal of Comparative Psychology 1986 100 2 101 107 2-s2.0-0022739171
9. Jones N., King S. M., Duxon M. S., Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide. Behavioural Pharmacology 2002 13 7 525 535 2-s2.0-0036855832 (Pubitemid 35387413)
10. Jones N., Duxon M. S., King S. M., Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents. Psychopharmacology 2002 161 3 314 323 2-s2.0-0035991072 10.1007/s00213-002-1029-y (Pubitemid 34591670)
11. Graeff F. G., Ferreira Netto C., Zangrossi H., The elevated T-maze as an experimental model of anxiety. Neuroscience and Biobehavioral Reviews 1998 23 2 237 246 2-s2.0-0345490863 10.1016/S0149-7634(98)00024-4 (Pubitemid 29011625)
12. Hogg S., Michan L., Jessa M., Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety. Neuropharmacology 2006 51 1 141 145 2-s2.0-33745215617 10.1016/j.neuropharm. 2006.03.009
13. Zanoveli J. M., Nogueira R. L., Zangrossi H., Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 2007 52 4 1188 1195 2-s2.0-33847280368 10.1016/j.neuropharm. 2007.01.001
14. Bertoglio L. J., de Bortoli V. C., Zangrossi H., Cholecystokinin-2 receptors modulate freezing and escape behaviors evoked by the electrical stimulation of the rat dorsolateral periaqueductal gray. Brain Research 2007 1156 1 133 138 2-s2.0-34250361853 10.1016/j.brainres.2007.04.038 (Pubitemid 46920513)
15. De Bortoli V. C., Nogueira R. L., Zangrossi H., Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. Psychopharmacology 2008 198 3 341 349 2-s2.0-44249099434 10.1007/s00213-008-1134-7
16. Zanoveli J. M., Pobbe R. L. H., De Bortoli V. C., Carvalho M. C., Brando M. L., Zangrossi H., Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. International Journal of Neuropsychopharmacology 2010 13 8 1079 1088 2-s2.0-77957240289 10.1017/S146114570999099X
17. Zanoveli J. M., Nogueira R. L., Zangrossi H., Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. European Journal of Pharmacology 2003 473 2-3 153 161 2-s2.0-0041743267 10.1016/S0014-2999(03)01970-8 (Pubitemid 36934488)
18. Shekhar A., DiMicco J. A., Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology 1987 26 5 407 417 2-s2.0-0023259612 (Pubitemid 17067174)
19. Shekhar A., Effects of treatment with imipramine and clonazepam on an animal model of panic disorder. Biological Psychiatry 1994 36 11 748 758 2-s2.0-0028104728 (Pubitemid 24365882)
20. Graeff F. G., Del-Ben C. M., Neurobiology of panic disorder: from animal models to brain neuroimaging. Neuroscience and Biobehavioral Reviews 2008 32 7 1326 1335 2-s2.0-50849092518 10.1016/j.neubiorev.2008.05.017
21. Johnson P. L., Truitt W., Fitz S. D., Minick P. E., Dietrich A., Sanghani S., Träskman-Bendz L., Goddard A. W., Brundin L., Shekhar A., A key role for orexin in panic anxiety. Nature Medicine 2010 16 1 111 115 2-s2.0-73849143579 10.1038/nm.2075
22. Yamashita P. S. D. M., De Bortoli V. C., Zangrossi H., 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray. Neuropharmacology 2011 60 2-3 216 222 2-s2.0-78650809140 10.1016/j.neuropharm. 2010.09.001
23. Pobbe R. L. H., Zangrossi H., Blanchard D. C., Blanchard R. J., Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. European Neuropsychopharmacology 2010 2-s2.0-77952735345 10.1016/j.euroneuro.2010.05.004
24. Miguel T. L. B., Pobbe R. L. H., Spiacci A., Zangrossi H., Dorsal raphe nucleus regulation of a panic-like defensive behavior evoked by chemical stimulation of the rat dorsal periaqueductal gray matter. Behavioural Brain Research 2010 213 2 195 200 2-s2.0-77953915330 10.1016/j.bbr.2010.04.055
25. Casarotto P. C., De Bortoli V. C., De Aguiar Corra F. M., Moraes Resstel L. B., Zangrossi H., Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA. International Journal of Neuropsychopharmacology 2010 13 5 573 582 2-s2.0-77953538200 10.1017/S146114570999112X
26. Borelli K. G., Nobre M. J., Brandao M. L., Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter. Behavioural Brain Research 2004 77 3 557 566 (Pubitemid 38296816)
27. Santos J. M., Martinez R. C. R., Brandão M. L., Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning. European Journal of Pharmacology 2006 542 1-3 121 128 2-s2.0-33746005569 10.1016/j.ejphar.2006.06. 019 (Pubitemid 44066375)
28. Blanchard R. J., Blanchard D. C., Antipredator defensive behaviors in a visible burrow system. Journal of Comparative Psychology 1989 103 1 70 82 2-s2.0-0024856827
29. Helbing D., Farkas I., Vicsek T., Simulating dynamical features of escape panic. Nature 2000 407 6803 487 490 2-s2.0-0034727079 10.1038/35035023
30. Kang J., Wright D.K., Qin S. F., Zhao Y., Modeling human behaviors and reactions under dangerous environment. Biomedical Sciences Instrumentation 2005 42 265 270
31. Saloma C., Perez G. J., Tapang G., Lim M., Palmes-Saloma C., Self-organized queuing and scale-free behavior in real escape panic. Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 11947 11952 2-s2.0-0142123146 10.1073/pnas.2031912100 (Pubitemid 37271495)
32. Blanchard D. C., Hori K., Rodgers R. J., Hendrie C. A., Blanchard R. J., Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines. Psychopharmacology 1989 97 3 392 401 2-s2.0-0024577676 (Pubitemid 19103435)
33. Richter-Levin G., Acute and long-term behavioral correlates of underwater trauma- potential relevance to stress and post-stress syndromes. Psychiatry Research 1998 79 1 73 83 2-s2.0-0032474555 10.1016/S0165-1781(98)00030-4 (Pubitemid 28318245)
34. Cohen H., Zohar J., Matar M. A., Zeev K., Loewenthal U., Richter-Levin G., Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 2004 29 11 1962 1970 2-s2.0-8444239739 10.1038/sj.npp.1300523 (Pubitemid 39486547)
35. Bouwer C., Stein D. J., Association of panic disorder with a history of traumatic suffocation. American Journal of Psychiatry 1997 154 11 1566 1570 2-s2.0-0030735229 (Pubitemid 27471350)
36. Severson C. A., Wang W., Pieribone V. A., Dohle C. I., Richerson G. B., Midbrain serotonergic neurons are central pH chemoreceptors. Nature Neuroscience 2003 6 11 1139 1140 2-s2.0-0242353161 10.1038/nn1130 (Pubitemid 37346031)
37. Gorman J. M., Liebowitz M. R., Fyer A. J., Stein J., A neuroanatomical hypothesis for panic disorder. American Journal of Psychiatry 1989 146 2 148 161 2-s2.0-0024602498 (Pubitemid 19059560)
38. Abelson J. L., Weg J. G., Nesse R. M., Curtis G. C., Persistent respiratory irregularity in patients with panic disorder. Biological Psychiatry 2001 49 7 588 595 2-s2.0-0035312420 10.1016/S0006-3223(00)01078-7 (Pubitemid 32289353)
39. Bouton M. E., Mineka S., Barlow D. H., A modern learning theory perspective on the etiology of panic disorder. Psychological Review 2001 108 1 4 32 2-s2.0-0035220285 (Pubitemid 33604124)
40. Bakker A., Van Balkom A. J. L. M., Van Dyck R., Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia. International Clinical Psychopharmacology 2000 15 2 S25 S30 2-s2.0-0033736238
41. Garakani H., Zitrin C. M., Klein D. F., Treatment of panic disorder with imipramine alone. American Journal of Psychiatry 1984 141 3 446 448 2-s2.0-0021366076 (Pubitemid 14194858)
42. Kasper S., Resinger E., Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors. European Neuropsychopharmacology 2001 11 4 307 321 2-s2.0-0034856710 10.1016/S0924-977X(01)00100-6 (Pubitemid 32781011)
43. Zitrin C. M., Klein D. F., Woerner M. G., Ross D. C., Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry 1983 40 2 125 138 2-s2.0-0020696997 (Pubitemid 13178009)
44. Connor K. M., Sutherland S. M., Tupler L. A., Malik M. L., Davidson J. R. T., Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. British Journal of Psychiatry 1999 175 17 22 2-s2.0-0032985613 (Pubitemid 29307850)
45. Falcon S., Ryan C., Chamberlain K., Curtis G., Tricyclics: possible treatment for posttraumatic stress disorder. Journal of Clinical Psychiatry 1985 46 9 385 388 2-s2.0-0021934319 (Pubitemid 15226969)
46. Frank J. B., Kosten T. R., Giller E. L., Dan E., A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. American Journal of Psychiatry 1988 145 10 1289 1291 2-s2.0-0023753085
47. Martenyi F., Brown E. B., Zhang H., Prakash A., Koke S. C., Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry 2002 63 3 199 206 2-s2.0-0036102127 (Pubitemid 34407078)
48. Saran A., Halaris A., Panic attack precipitated by fluoxetine. The Journal of Neuropsychiatry and Clinical Neurosciences 1989 1 2 219 220
49. den Boer J. A., Westenberg H. G., Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 1990 102 1 85 94 (Pubitemid 20227533)
50. Catalano G., Hakala S. M., Catalano M. C., Sertraline-induced panic attacks. Clinical Neuropharmacology 2000 23 3 164 168 2-s2.0-0034129586 10.1097/00002826-200005000-00007 (Pubitemid 30395379)
51. Fontaine R., Chouinard G., Annable L., Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal. Psychopharmacology Bulletin 1984 20 1 126 127 2-s2.0-0021173869 (Pubitemid 14128885)
52. Pourmotabbed T., Mcleod D. R., Hoehn-Saric R., Hipsley P., Greenblatt D. J., Treatment, discontinuation, and psychomotor effects of diazepam in women with generalized anxiety disorder. Journal of Clinical Psychopharmacology 1996 16 3 202 207 2-s2.0-0029927317 10.1097/00004714-199606000-00002 (Pubitemid 26227916)
53. Nardi A. E., Freire R. C., Valença A. M., Amrein R., De Cerqueira A. C. R., Lopes F. L., Nascimento I., Mezzasalma M. A., Veras A. B., Sardinha A., De Carvalho M. R., Da Costa R. T., Levitan M. N., De-Melo-Neto V. L., Soares-Filho G. L., Versiani M., Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. Journal of Clinical Psychopharmacology 2010 30 3 290 293 2-s2.0-77952384787 10.1097/JCP. 0b013e3181dcb2f3
54. Nardi A. E., Freire R. C., Valença A. M., Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine. Journal of Clinical Psychopharmacology 2011 31 2 259 261
55. Griebel G., Perrault G., Sanger D. J., Characterization of the behavioral profile of the non peptide CRF receptor antagonist GP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology 1998 138 1 55 66 2-s2.0-0031854080 10.1007/s002130050645 (Pubitemid 28319048)
56. Griebel G., Blanchard D. C., Agnes R. S., Blanchard R. J., Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 1995 120 1 57 66 2-s2.0-0029029049 10.1007/BF02246145
57. Teixeira R. C., Zangrossi H., Graeff F., Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacology Biochemistry and Behavior 2000 65 4 571 576 (Pubitemid 30182498)
58. Christianson J. P., Drugan R. C., Intermittent cold water swim stress increases immobility and interferes with escape performance in rat. Behavioural Brain Research 2005 165 1 58 62 2-s2.0-26944491836 10.1016/j.bbr.2005.06.028 (Pubitemid 41476204)
59. Retana-Márquez S., Bonilla-Jaime H., Vázquez-Palacios G., Martínez-García R., Velázquez-Moctezuma J., Changes in masculine sexual behavior, corticosterone and testosterone in response to acute and chronic stress in male rats. Hormones and Behavior 2003 44 4 327 337 2-s2.0-18544404792 10.1016/j.yhbeh.2003.04.001 (Pubitemid 37378212)
60. Morris R., Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 1984 11 1 47 60 2-s2.0-0021173996 10.1016/0165-0270(84)90007-4 (Pubitemid 14088970)
61. Klein D. F., False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Archives of General Psychiatry 1993 50 4 306 317 2-s2.0-0027528446 (Pubitemid 23115374)
62. Barlow D. H., Anxiety and its Disorders. The Nature and Treatment of Anxiety and Panic 1988 New York, NY, USA Guilford Press
63. Fyer M. R., Uy J., Martinez J., Goetz R., Klein D. F., Fyer A., Liebowitz M. R., Gorman J., CO2 challenge of patients with panic disorder. American Journal of Psychiatry 1987 144 8 1080 1082 2-s2.0-0023160559 (Pubitemid 17143575)
64. Griez E. J. L., Lousberg H., Van den Hout M. A., Van der Molen G. M., CO2 vulnerability in panic disorder. Psychiatry Research 1987 20 2 87 95 2-s2.0-0023160040
65. Gorman J. M., Papp L. A., Coplan J. D., Martinez J. M., Lennon S., Goetz R. R., Ross D., Klein D. F., Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder. American Journal of Psychiatry 1994 151 4 547 553 2-s2.0-0028182226 (Pubitemid 24115820)
66. Uhde T. W., Roy-Byrne P. P., Caffeine: practical facts for the psychiatrist. Anxiety: New Research Findings for the Clinician 1988 Washington, DC, USA American Psychiatric Press 73 88
67. Gorman J. M., Goetz R. R., Dillon D., Liebowitz M. R., Fyer A. J., Davies S., Klein D. F., Sodium D-lactate infusion of panic disorder patients. Neuropsychopharmacology 1990 3 3 181 190 2-s2.0-0025315497 (Pubitemid 20182765)
68. Abelson J. L., Nesse R. M., Weg J. G., Curtis G. C., Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosomatic Medicine 1996 58 4 302 313 2-s2.0-0029896019 (Pubitemid 26250588)
69. Gutman D. A., Coplan J., Papp L., Martinez J., Gorman J., Doxapram-induced panic attacks and cortisol elevation. Psychiatry Research 2005 133 2-3 253 261 2-s2.0-14644432395 10.1016/j.psychres.2004.10.010 (Pubitemid 40312158)
70. Kent J. M., Coplan J. D., Mawlawi O., Martinez J. M., Browne S. T., Slifstein M., Martinez D., Abi-Dargham A., Laruelle M., Gorman J. M., Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. American Journal of Psychiatry 2005 162 7 1379 1381 2-s2.0-21344447758 10.1176/appi.ajp.162.7.1379 (Pubitemid 40905592)
71. Sullivan G. M., Apergis J., Gorman J. M., LeDoux J. E., Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala. Biological Psychiatry 2003 53 10 863 870 2-s2.0-0037721660 10.1016/S0006- 3223(02)01733-X (Pubitemid 36556171)
72. Metz G. A., Jadavji N. M., Smith L. K., Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. European Journal of Neuroscience 2005 22 5 1190 1200 2-s2.0-25844444170 10.1111/j.1460-9568.2005.04285.x (Pubitemid 41395384)
73. Pardon M. C., Ma S., Morilak D. A., Chronic cold stress sensitizes brain noradrenergic reactivity and noradrenergic facilitation of the HPA stress response in Wistar Kyoto rats. Brain Research 2003 971 1 55 65 2-s2.0-0037414409 10.1016/S0006-8993(03)02355-2 (Pubitemid 36412064)
74. Tazumi T., Hori E., Uwano T., Umeno K., Tanebe K., Tabuchi E., Ono T., Nishijo H., Effects of prenatal maternal stress by repeated cold environment on behavioral and emotional development in the rat offspring. Behavioural Brain Research 2005 162 1 153 160 2-s2.0-19444374256 10.1016/j.bbr.2005.03.006 (Pubitemid 40726289)
75. Jedema H. P., Grace A. A., Chronic exposure to cold stress alters electrophysiological properties of locus coeruleus neurons recorded in vitro. Neuropsychopharmacology 2003 28 1 63 72 2-s2.0-0037209009
76. Suess W. M., Alexander A. B., Smith D. D., The effects of psychological stress on respiration: a preliminary study of anxiety and hyperventilation. Psychophysiology 1980 17 6 535 540 2-s2.0-0019178147 (Pubitemid 11238633)
77. Datta A., Tipton M., Respiratory responses to cold water immersion: neural pathways, interactions, and clinical consequences awake and asleep. Journal of Applied Physiology 2006 100 6 2057 2064 2-s2.0-33744908556 10.1152/japplphysiol.01201.2005 (Pubitemid 43845882)
78. Klenerová V., Kaminský O., Šída P., Krejčí I., Hliák Z., Hynie S., Impaired passive avoidance acquisition in Sprague-Dawley and Lewis rats after restraint and cold stress. Behavioural Brain Research 2002 136 1 21 29 2-s2.0-0037126151 10.1016/S0166-4328(02)00093-1 (Pubitemid 35246388)
79. Klenerová V., Jurčovičová J., Kaminský O., Šída P., Krejčí I., Hliňák Z., Hynie S., Combined restraint and cold stress in rats: effects on memory processing in passive avoidance task and on plasma levels of ACTH and corticosterone. Behavioural Brain Research 2003 142 1-2 143 149 2-s2.0-0037940104 10.1016/S0166-4328(02)00401-1 (Pubitemid 36677600)
80. Klenerová V., Sida P., Krejci I., Effects of two types of restraint stress on spontaneous behavior of Sprague-Dawley and Lewis rats. Journal of Physiology and Pharmacology 2007 58 1 83 94 (Pubitemid 350021139)
81. Vargas L. C., Schenberg L. C., Long-term effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked innate defensive behaviours of the rat. Psychopharmacology 2001 155 3 260 268 2-s2.0-0035015983 10.1007/s002130100698 (Pubitemid 32477282)
82. Harvey B. H., Naciti C., Brand L., Stein D. J., Serotonin and stress: protective or malevolent actions in the biobehavioral response to repeated trauma? Annals of the New York Academy of Sciences 2004 1032 267 272 2-s2.0-14544290436 10.1196/annals.1314.035 (Pubitemid 40298490)
83. Matar M. A., Cohen H., Kaplan Z., Zohar J., The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2006 31 12 2610 2618 2-s2.0-33746417807 10.1038/sj.npp.1301132 (Pubitemid 44764158)
84. Takahashi T., Morinobu S., Iwamoto Y., Yamawaki S., Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats. Psychopharmacology 2006 189 2 165 173 2-s2.0-33750609342 10.1007/s00213-006- 0545-6 (Pubitemid 44691539)
85. Jacob C. A., Caabral A. H., Almeida L. P., Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacology Biochemistry and Behavior 2002 72 4 761 766 (Pubitemid 34621302)
86. Blanchard R. J., Shepherd J. K., Rodgers R. J., Magee L., Blanchard D. C., Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology 1993 110 1-2 245 253 2-s2.0-0027508979 (Pubitemid 23029458)
87. Nutt D. J., The pharmacology of human anxiety. Pharmacology and Therapeutics 1990 47 2 233 266 2-s2.0-0025336843 10.1016/0163-7258(90)90089-K (Pubitemid 20228582)
88. Li S., Murakami Y., Wang M., The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder. Pharmacology Biochemistry and Behavior 2006 85 2 324 331 (Pubitemid 44889260)
89. Cates M. E., Bishop M. H., Davis L. L., Lowe J. S., Woolley T. W., Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Annals of Pharmacotherapy 2004 38 9 1395 1399 2-s2.0-4143116598 10.1345/aph.1E043 (Pubitemid 39100190)
90. Gelpin E., Bonne O., Peri T., Brandes D., Shalev A. Y., Treatment of recent trauma survivors with benzodiazepines: a prospective study. Journal of Clinical Psychiatry 1996 57 9 390 394 2-s2.0-0029744009 (Pubitemid 26321989)
91. Pitman R. K., Delahanty D. L., Conceptually driven pharmacologic approaches to acute trauma. CNS Spectrums 2005 10 2 99 106 2-s2.0-14744267550 (Pubitemid 40327774)
92. Jenck F., Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Research 1995 57 2 181 191 2-s2.0-0029134515 10.1016/0165-1781(95)02673-K
93. Tesar G. E., Rosenbaum J. F., Pollack M. H., Otto M. W., Sachs G. S., Herman J. B., Cohen L. S., Spier S. A., Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. Journal of Clinical Psychiatry 1991 52 2 69 76 2-s2.0-0026030016
94. Schenberg L. C., Capucho L. B., Vatanabe R. O., Vargas L. C., Acute effects of clomipramine and fluoxetine on dorsal periaqueductal grey-evoked unconditioned defensive behaviours of the rat. Psychopharmacology 2002 159 2 138 144 2-s2.0-0036169150 10.1007/s002130100883 (Pubitemid 34146556)
95. Bourin M., Lambert O., Pharmacotherapy of anxious disorders. Human Psychopharmacology 2002 17 8 383 400 2-s2.0-0036904318 10.1002/hup.435 (Pubitemid 35469348)